Avid Bioservices, Inc. Quarterly Liabilities in USD from Q1 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.
Summary
Avid Bioservices, Inc. quarterly Liabilities history and growth rate from Q1 2019 to Q3 2024.
  • Avid Bioservices, Inc. Liabilities for the quarter ending October 31, 2024 was $279M, a 2.4% increase year-over-year.
Liabilities, Quarterly (USD)
Liabilities, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $279M +$6.52M +2.4% Oct 31, 2024 10-Q 2024-12-10
Q2 2024 $276M +$23.3M +9.21% Jul 31, 2024 10-Q 2024-09-09
Q1 2024 $276M +$13.3M +5.06% Apr 30, 2024 10-Q 2024-12-10
Q4 2023 $275M +$9.39M +3.54% Jan 31, 2024 10-Q 2024-04-24
Q3 2023 $272M +$11M +4.23% Oct 31, 2023 10-Q/A 2024-04-24
Q2 2023 $253M -$19.7M -7.22% Jul 31, 2023 10-Q/A 2024-04-24
Q1 2023 $262M +$7.08M +2.77% Apr 30, 2023 10-K 2024-07-02
Q4 2022 $266M +$8.15M +3.16% Jan 31, 2023 10-K/A 2024-04-24
Q3 2022 $261M +$10.6M +4.22% Oct 31, 2022 10-K/A 2024-04-24
Q2 2022 $272M Jul 31, 2022 10-K/A 2024-04-24
Q1 2022 $255M +$67.5M +36% Apr 30, 2022 10-K/A 2024-04-24
Q4 2021 $258M +$175M +211% Jan 31, 2022 10-Q 2022-03-08
Q3 2021 $251M +$186M +290% Oct 31, 2021 10-Q 2021-12-07
Q1 2021 $188M +$122M +186% Apr 30, 2021 10-K 2022-06-29
Q4 2020 $82.8M +$24.7M +42.4% Jan 31, 2021 10-Q 2021-03-08
Q3 2020 $64.2M Oct 31, 2020 10-Q 2020-12-02
Q2 2020 $59M Jul 31, 2020 10-Q 2020-09-01
Q1 2020 $65.7M +$40.4M +160% Apr 30, 2020 10-K 2021-06-29
Q4 2019 $58.1M Jan 31, 2020 10-Q 2020-03-10
Q1 2019 $25.3M Apr 30, 2019 10-K 2020-06-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.